PPhoCUs: Polypharmacy, Pharmacists and Clinical Uncertainty

  • Research type

    Research Study

  • Full title

    PPhoCUs: Polypharmacy, Pharmacists and Clinical Uncertainty

  • IRAS ID

    336527

  • Contact name

    Tomazo Kallis

  • Contact email

    t.j.kallis@exeter.ac.uk

  • Sponsor organisation

    University of Exeter

  • Clinicaltrials.gov Identifier

    2022-23-31, Sponsor Reference

  • Duration of Study in the UK

    1 years, 4 months, 30 days

  • Research summary

    People prescribed a large number of drugs (more than 10) are more likely to be admitted to hospital, suffer a life-changing fall or be generally more unwell, than people who do not regularly take a large number of medicines. The more medical conditions a person has and the greater number of medicines a person is prescribed, the more difficult decision making can become for healthcare professionals giving advice or treating that patient. When the next best step for a patient is unclear, this is referred to as ‘clinical uncertainty.’
    Pharmacists have been introduced to GP practices over the past five years and although they are experts in medicines, their university training is not enough for pharmacists to start working in GP practices independently after qualifying. Pharmacists need to undertake further nationally recommended postgraduate training for 18 months to enable this. Although their training is robust, pharmacists can struggle making decisions in situations of clinical uncertainty, as their training does not focus on this in the same way that GP training does. This is important, as one of the key things pharmacists in GP practice are employed to do is review patients on large numbers of medicines.
    This study will analyse audio recordings taken from patient appointments with GP pharmacists to understand how they make their decisions with people. Both the pharmacists and patients will be invited separately to individual interviews to share their experiences. Pharmacists will be asked how they make their decisions in practice when faced with clinical uncertainty. Patients will be invited to share their experience of their GP pharmacist appointment. Findings from these interviews and recordings will help develop future recommendations for pharmacist education and practice in GP settings.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    24/YH/0120

  • Date of REC Opinion

    27 Jun 2024

  • REC opinion

    Further Information Favourable Opinion